Residual renal function in chronic dialysis is not associated with reduced erythropoietin-stimulating agent dose requirements: a cross-sectional study.

about

Residual renal function in chronic dialysis is not associated with reduced erythropoietin-stimulating agent dose requirements: a cross-sectional study.

Item

http://www.wikidata.org/entity/Q46523502

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Residual renal function in chr ...... ents: a cross-sectional study.

@en

Residual renal function in chr ...... ents: a cross-sectional study.

@nl

type

Item

label

Residual renal function in chr ...... ents: a cross-sectional study.

@en

Residual renal function in chr ...... ents: a cross-sectional study.

@nl

prefLabel

Residual renal function in chr ...... ents: a cross-sectional study.

@en

Residual renal function in chr ...... ents: a cross-sectional study.

@nl

P1476

Residual renal function in chr ...... ents: a cross-sectional study.

@en

P2093

Elizabeth Helene Louw

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of peritoneal dialysis versus hemodialysis on renal anemia in renal in end-stage disease patients: a meta-analysis.

Mortality associated with dose response of erythropoiesis-stimulating agents in hemodialysis versus peritoneal dialysis patients.

Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.

Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.

Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics

Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients

Hematocrit-lowering effect following inactivation of renin-angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers.

Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients.

Erythropoiesis-stimulating agent hyporesponsiveness.

The greatly misunderstood erythropoietin resistance index and the case for a new responsiveness measure.

P2888

s12882-017-0752-x

P304

336

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12882-017-0752-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mogamat-Yazied Chothia

P577

2017-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092976839

http://www.w3.org/2001/XMLSchema#string

P698

29178879

http://www.w3.org/2001/XMLSchema#string

P921

Erythropoietin

P932

5702117

http://www.w3.org/2001/XMLSchema#string